Company news
Icon Plc (NASDAQ:ICLR) news
Icon Plc news releases on 6ix. Latest, Aug 14, 2024: ICON Announces Appointment of New Chief Financial Officer
Press releases — page 2
ICON Announces Appointment of New Chief Financial Officer
August 13, 2024
ICON Reports Second Quarter 2024 Results
July 23, 2024
ICON announces results of Annual General Meeting and changes to the Board of Directors
July 23, 2024
ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer
July 9, 2024
ICON plc Schedules Second Quarter 2024 Earnings Conference Call
June 30, 2024
ICON plc to Present at the Jefferies Global Healthcare Conference
June 3, 2024
ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance
May 29, 2024
ICON plc to hold Investor Day Meeting on May 30, 2024
May 19, 2024
ICON releases its ICON Cares 2023 Report
May 8, 2024
ICON Announces Pricing of USD 2 Billion Notes
April 29, 2024
ICON Reports First Quarter 2024 Results
April 23, 2024
ICON Announces CFO Transition
April 2, 2024
ICON plc Schedules First Quarter 2024 Earnings Conference Call
March 24, 2024
ICON Reports Fourth Quarter and Full Year 2023 Results
February 20, 2024
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
January 29, 2024
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment
January 23, 2024
ICON Issues Financial Guidance for Full Year 2024
January 8, 2024
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON
January 7, 2024
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 3, 2024
ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023
December 17, 2023
ICON Secures Upgraded Credit Rating from Moody’s Investors Service
December 6, 2023
ICON Reports Third Quarter 2023 Results
October 24, 2023
ICON Secures Upgraded Credit Rating from S&P Global Ratings
October 11, 2023
ICON plc Schedules Third Quarter 2023 Earnings Conference Call
September 20, 2023
ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution
September 19, 2023
BARDA Partners With ICON to Execute Next Generation COVID-19 Vaccines Clinical Trial
September 12, 2023
ICON plc to Present at the Baird Global Healthcare Conference
September 5, 2023
ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
July 25, 2023
ICON Reports Second Quarter 2023 Results
July 25, 2023
First Half of 2023 Sees ICON Recognised for CRO Excellence, Alongside Industry Awards as an Employer of Choice and for Its Creative and Digital Services
July 12, 2023
ICON plc Schedules Second Quarter 2023 Earnings Conference Call
June 26, 2023
ICON Releases Latest Version of its Digital Platform, Providing Integrated Patient Services and Harmonised Data in One Platform
June 25, 2023
ICON plc Set to Join Russell 3000® Index
June 25, 2023
ICON plc to Attend Upcoming Investor Conferences
May 30, 2023
ICON releases its 2022 ICON Cares ESG Report
May 15, 2023
ICON Reports First Quarter 2023 Results
April 25, 2023
ICON plc Schedules First Quarter 2023 Earnings Conference Call
March 28, 2023
LEO Pharma and ICON Enter a Strategic Partnership to Propel Clinical Trial Execution Within Medical Dermatology
March 9, 2023
ICON Reports Fourth Quarter and Full Year 2022 Results
February 21, 2023
ICON plc Schedules Fourth Quarter 2022 Earnings Conference Call
January 25, 2023
ICON Issues Financial Guidance for Full Year 2023
January 9, 2023
ICON plc to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 2, 2023
ICON recognised as leading contract research organisation and employer by Scrip, Fierce Life Sciences, Financial Times and others
December 12, 2022
ICON plc to Present at the 2022 Evercore ISI HealthCONx Conference
November 22, 2022
ICON Reports Third Quarter 2022 Results
November 1, 2022
ICON selected by BARDA to conduct anthrax vaccine clinical trial
October 5, 2022
ICON plc Schedules Third Quarter 2022 Earnings Conference Call
September 25, 2022
ICON Releases its 2021 ESG Report
September 5, 2022
ICON plc to Present at the 2022 Wells Fargo Healthcare Conference
August 30, 2022
ICON Reports Second Quarter 2022 Results
July 26, 2022